AU9672598A - Galenic forms of r-or rr-isomers of adrenergic beta-2 agonists - Google Patents

Galenic forms of r-or rr-isomers of adrenergic beta-2 agonists

Info

Publication number
AU9672598A
AU9672598A AU96725/98A AU9672598A AU9672598A AU 9672598 A AU9672598 A AU 9672598A AU 96725/98 A AU96725/98 A AU 96725/98A AU 9672598 A AU9672598 A AU 9672598A AU 9672598 A AU9672598 A AU 9672598A
Authority
AU
Australia
Prior art keywords
agonists
isomers
galenic forms
adrenergic beta
adrenergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU96725/98A
Inventor
E. Charles Jr. +di Pesterfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ec Pesterfield Associates Inc
Original Assignee
E C PESTERFIELD ASSOCIATES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E C PESTERFIELD ASSOCIATES Inc filed Critical E C PESTERFIELD ASSOCIATES Inc
Publication of AU9672598A publication Critical patent/AU9672598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
AU96725/98A 1997-09-30 1998-09-30 Galenic forms of r-or rr-isomers of adrenergic beta-2 agonists Abandoned AU9672598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94042597A 1997-09-30 1997-09-30
US08940425 1997-09-30
PCT/US1998/020390 WO1999016430A1 (en) 1997-09-30 1998-09-30 Galenic forms of r-or rr-isomers of adrenergic beta-2 agonists

Publications (1)

Publication Number Publication Date
AU9672598A true AU9672598A (en) 1999-04-23

Family

ID=25474813

Family Applications (1)

Application Number Title Priority Date Filing Date
AU96725/98A Abandoned AU9672598A (en) 1997-09-30 1998-09-30 Galenic forms of r-or rr-isomers of adrenergic beta-2 agonists

Country Status (2)

Country Link
AU (1) AU9672598A (en)
WO (1) WO1999016430A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10019877B2 (en) 2005-04-03 2018-07-10 Qognify Ltd. Apparatus and methods for the semi-automatic tracking and examining of an object or an event in a monitored site
BRPI0716495A2 (en) 2006-08-10 2014-03-04 Us Gov Health & Human Serv (R, R) - PHENOTEROL AND (R, R) - OR (R, S) - PHENOTEROL ANALOGUE, USE OF THE SAME IN THE PREPARATION OF PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL COMPOSITION UNDERSTANDING SUCH COMPOUNDS.
WO2011112867A1 (en) 2010-03-10 2011-09-15 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
WO2020051568A1 (en) * 2018-09-08 2020-03-12 Wen Tan NEW USE OF R-ENANTIOMER OF ADRENERGIC β2 RECEPTOR AGONISTS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND ITS EXTRA INTESTINAL MANIFESTATIONS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2100599B (en) * 1981-06-30 1985-01-03 Dispersa Ag Pharmaceutical preparation for treating glaucoma and ocular hypertension

Also Published As

Publication number Publication date
WO1999016430A1 (en) 1999-04-08

Similar Documents

Publication Publication Date Title
AU1285499A (en) Somatostatin agonists
AU6596198A (en) Transverse rod connector clip
AU6856698A (en) High-molecular polyamide
AU9549698A (en) Surgical clip
AU7349298A (en) Prostaglandin agonists
AU5218596A (en) Beta-adrenergic agonists
AU1926000A (en) Pth1r and pth3r receptors
AUPO518297A0 (en) Improved joint structure
AU9512298A (en) Beta3-adrenoreceptor agonists, agonist compositions and methods of using
AU5338699A (en) Imidazoles and related compounds as alpha1a agonists
AU9367198A (en) Enzymatic modification
AUPO885297A0 (en) Compression engine
AU9672598A (en) Galenic forms of r-or rr-isomers of adrenergic beta-2 agonists
AU5490099A (en) Manufacture of alpha-olefins
AU3344499A (en) Hypoglycemic agents
AU8061798A (en) Network object cache engine
AUPO695497A0 (en) End of line pipeliner
AU1698899A (en) N-acetylserotonin derivatives and uses thereof
AU1505999A (en) Immunosuppressant agonists
AU1046799A (en) Compound, composition and use
AU8736698A (en) Shale-stabilizing additives
AU6965398A (en) Preparation of thiazoles using 1,3-dihalopropenes
AU8029498A (en) Clip
AU699704B2 (en) Afforestation of degraded land
AU1594099A (en) Hydrofluorocarbon refrigerants

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase